This contract expires in 277 days (Jan 18, 2027).
FIRM FIXED PRICE
EXELAN PHARMACEUTICALS INC - LENALIDOMIDE - ONCOLOGY TREATMENT FOR VETERANS DIFFERENT MILLIGRAMS.
PIID: 36C26026F0144
Signed Date: Jan 14, 2026Effective Date: Jan 19, 2026End Date: Closes in 277 days
Key Details
Description
LENALIDOMIDE - ONCOLOGY TREATMENT FOR VETERANS DIFFERENT MILLIGRAMS.
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.